| |
| |
|
| Insider
Information: |
Oliviero James F Iii |
| Relationship: |
Director |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
2,221,014 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$3,783,364 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
2,221,014 |
|
|
| Total
Value |
$3,783,364 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
15
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
15
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-15.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -763.7%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Keryx Biopharmaceuticals Inc |
KERX |
Chief Financial Officer |
2015-07-06 |
209,406 |
2008-08-14 |
0 |
Premium* |
|
|
Checkpoint Therapeutics, Inc. |
CKPT |
CEO, President and Dir... |
2024-05-24 |
2,001,780 |
|
0 |
Premium* |
|
|
Nuvectis Pharma, Inc. |
NVCT |
Director |
2022-02-08 |
9,828 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
81 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| KERX |
Keryx Biopharmaceuticals ... |
Chief Financial Officer |
• – – |
2011-10-03 |
4 |
S |
$2.82 |
$17,192 |
D/D |
(6,105) |
161,208 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chief Financial Officer |
• – – |
2014-01-03 |
4 |
S |
$12.57 |
$79,304 |
D/D |
(6,309) |
492,861 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chief Financial Officer |
• – – |
2012-01-03 |
4 |
S |
$2.63 |
$18,874 |
D/D |
(7,190) |
182,018 |
0 |
- |
|
| CKPT |
Checkpoint Therapeutics, ... |
CEO, President and Director |
• • – |
2024-02-28 |
4 |
GD |
$0.00 |
$0 |
D/D |
9,056 |
341,780 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chief Financial Officer |
• – – |
2010-08-20 |
4 |
S |
$3.84 |
$38,400 |
D/D |
(10,000) |
358,041 |
0 |
- |
|
| CKPT |
Checkpoint Therapeutics, ... |
CEO, President and Director |
• • – |
2023-02-01 |
4 |
S |
$4.77 |
$48,945 |
D/D |
(10,261) |
182,121 |
0 |
% |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chief Financial Officer |
• – – |
2013-01-04 |
4 |
S |
$2.74 |
$29,754 |
D/D |
(10,859) |
589,689 |
0 |
- |
|
| CKPT |
Checkpoint Therapeutics, ... |
CEO, President and Director |
• • – |
2024-02-01 |
4 |
S |
$2.01 |
$23,919 |
D/D |
(11,900) |
369,680 |
0 |
% |
|
| CKPT |
Checkpoint Therapeutics, ... |
CEO, President and Director |
• • – |
2022-06-22 |
4 |
S |
$1.09 |
$13,080 |
D/D |
(12,000) |
2,577,003 |
0 |
% |
|
| CKPT |
Checkpoint Therapeutics, ... |
CEO, President and Director |
• • – |
2024-02-01 |
4 |
GD |
$0.00 |
$0 |
D/D |
12,950 |
356,730 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chief Financial Officer |
• – – |
2014-03-21 |
4 |
S |
$15.11 |
$203,139 |
D/D |
(13,444) |
304,417 |
0 |
- |
|
| CKPT |
Checkpoint Therapeutics, ... |
CEO, President and Director |
• • – |
2022-04-05 |
4 |
S |
$1.77 |
$24,833 |
D/D |
(14,030) |
2,859,261 |
0 |
% |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chief Financial Officer |
• – – |
2011-01-03 |
4 |
S |
$4.67 |
$65,679 |
D/D |
(14,064) |
223,645 |
0 |
- |
|
| CKPT |
Checkpoint Therapeutics, ... |
CEO, President and Director |
• • – |
2022-06-23 |
4 |
S |
$1.11 |
$16,650 |
D/D |
(15,000) |
2,562,003 |
0 |
% |
|
| CKPT |
Checkpoint Therapeutics, ... |
CEO, President and Director |
• • – |
2023-02-27 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
149,573 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chief Financial Officer |
• – – |
2011-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
16,250 |
237,709 |
0 |
- |
|
| CKPT |
Checkpoint Therapeutics, ... |
CEO, President and Director |
• • – |
2022-06-21 |
4 |
S |
$1.09 |
$22,890 |
D/D |
(21,000) |
2,589,003 |
0 |
% |
|
| CKPT |
Checkpoint Therapeutics, ... |
CEO, President and Director |
• • – |
2022-04-13 |
4 |
S |
$1.51 |
$32,100 |
D/D |
(21,258) |
2,838,003 |
0 |
% |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chief Financial Officer |
• – – |
2014-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
22,741 |
499,170 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chief Financial Officer |
• – – |
2010-01-05 |
4 |
S |
$2.60 |
$59,771 |
D/D |
(22,981) |
439,983 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chief Financial Officer |
• – – |
2015-01-04 |
4 |
A |
$0.00 |
$0 |
D/D |
23,875 |
177,220 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chief Financial Officer |
• – – |
2010-12-03 |
4 |
S |
$5.06 |
$122,199 |
D/D |
(24,150) |
225,059 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chief Financial Officer |
• – – |
2009-05-22 |
4 |
B |
$0.40 |
$9,925 |
D/D |
25,000 |
355,000 |
2.74 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chief Financial Officer |
• – – |
2014-12-10 |
4 |
S |
$15.69 |
$392,250 |
D/D |
(25,000) |
153,345 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chief Financial Officer |
• – – |
2012-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
28,000 |
189,208 |
0 |
- |
|
81 Records found
|
|
Page 2 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
